A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT07570823 · RECRUITING
Trial details
- NCT number
- NCT07570823
- Sponsor
- Sinocelltech Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-04
- Primary completion
- 2027-11-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.